BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crescenzi E, Leonardi A, Pacifico F. NGAL as a Potential Target in Tumor Microenvironment. Int J Mol Sci 2021;22:12333. [PMID: 34830212 DOI: 10.3390/ijms222212333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang W, Li X, Xiang C, Zhou W. Neutrophils in pancreatic cancer: Potential therapeutic targets. Front Oncol 2022;12:1025805. [DOI: 10.3389/fonc.2022.1025805] [Reference Citation Analysis]
2 Candido S, Tomasello B, Lavoro A, Falzone L, Gattuso G, Russo A, Paratore S, Mccubrey JA, Libra M. Bioinformatic analysis of the LCN2–SLC22A17–MMP9 network in cancer: The role of DNA methylation in the modulation of tumor microenvironment. Front Cell Dev Biol 2022;10:945586. [DOI: 10.3389/fcell.2022.945586] [Reference Citation Analysis]
3 Wang S, Zhang L, Hao D, Wang L, Liu J, Niu Q, Mi L, Peng X, Gao J. Research progress of risk factors and early diagnostic biomarkers of gout-induced renal injury. Front Immunol 2022;13:908517. [DOI: 10.3389/fimmu.2022.908517] [Reference Citation Analysis]
4 Lu Y, Zhu D, Le Q, Wang Y, Wang W. Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy. Nanoscale 2022. [DOI: 10.1039/d2nr02994d] [Reference Citation Analysis]